Autosomal recessive cerebellar ataxia type 1

From WikiMD's Food, Medicine & Wellnesspedia

Autosomal recessive cerebellar ataxia type 1 (ARCA1), also known as ARCA or SCAR1, is a rare genetic disorder that primarily affects the cerebellum. It is characterized by progressive ataxia, a condition that affects balance, coordination, and speech.

Symptoms[edit | edit source]

The symptoms of ARCA1 typically begin in early childhood and progressively worsen over time. These may include:

  • Ataxia: Difficulty with balance and coordination, which can affect walking and speech.
  • Dysarthria: Difficulty articulating words due to problems with muscle control.
  • Nystagmus: Involuntary eye movements.
  • Dysmetria: Difficulty judging distance or scale.
  • Muscle weakness: Particularly in the lower limbs.

Causes[edit | edit source]

ARCA1 is caused by mutations in the ATN1 gene. This gene provides instructions for making a protein that is involved in the normal functioning of nerve cells, particularly in the cerebellum. Mutations in the ATN1 gene disrupt this normal functioning, leading to the symptoms of ARCA1.

Diagnosis[edit | edit source]

Diagnosis of ARCA1 is based on clinical symptoms, family history, and genetic testing. Magnetic resonance imaging (MRI) may also be used to identify changes in the cerebellum.

Treatment[edit | edit source]

There is currently no cure for ARCA1. Treatment is supportive and aims to manage symptoms. This may include physical therapy, speech therapy, and medications to manage specific symptoms.

Prognosis[edit | edit source]

The prognosis for individuals with ARCA1 varies. The disorder is progressive, meaning symptoms typically worsen over time. However, the rate of progression can vary widely among individuals.

See also[edit | edit source]

References[edit | edit source]


‎ ‎


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD